Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-06-06Clinical Trial Update: DIabetic Retinopathy Candesartan Trials [Phase 3]
Phase 3 trials evaluating candesartan for diabetic retinopathy in patients with type 2 diabetes have completed and posted results.
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes [Phase 3]
Phase 3 efficacy and safety study of TA-7284 in adults with Type 2 Diabetes Mellitus has completed and results have been posted.
-
FDA approval · 2014-06-05FDA Approved: INVOKANA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved Janssen's supplemental application for INVOKANA (canagliflozin), resulting in updated labeling for the product.
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Safety and Efficacy Study of Albiglutide in Type 2 Diabetes [Phase 3]
Phase 3 safety and efficacy study of albiglutide in adults with type 2 diabetes completed with results posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes [Phase 2]
This document reports Phase 2 results for TA-7284 in patients with Type 2 Diabetes Mellitus, including efficacy, safety, and tolerability as…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-06-05Clinical Trial Update: Comparison of a New Formulation of Insulin Glargine With Lantus® Both in Combination With Oral Antihyperglycemic Drug(s) in Japanese Patients With Type 2 Diabetes Mellitus [Phase 3]
A Phase 3 trial comparing a new insulin glargine formulation with Lantus, both in combination with oral antidiabetic drugs, in Japanese pati…
-
CLINICAL_TRIALS withdrawal · 2014-06-05Clinical Trial Update: BE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States [Phase 1]
Phase 1 bioequivalence study comparing a fixed-dose combination tablet of saxagliptin 5 mg and metformin XR 500 mg to co-administered Saxagl…
-
FDA approval · 2014-06-04FDA Approved: BYETTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for BYETTA (exenatide) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2014-06-04FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro from Eli Lilly.
-
FDA approval · 2014-06-04FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) submitted by Eli Lilly and Company, likely updating labeli…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes [Phase 3]
This is a Phase 3 clinical trial update assessing the safety and efficacy of albiglutide in adults with Type 2 diabetes; the study has compl…
-
FDA approval · 2014-06-04FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro), expanding the availability of the 50/50 insulin l…
-
CLINICAL_TRIALS trial_result · 2014-06-04Clinical Trial Update: Evaluating a Web-Based Cardiovascular Disease Risk Factor Reduction Program Among American Indians [NA]
A completed clinical trial evaluating a web-based program to reduce cardiovascular risk factors in American Indian populations.
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Characterization of High Density Lipoprotein (HDL) in Type 2 Diabetes (T2D) After Fenofibrate or Niacin Treatment [Phase 4]
A completed Phase 4 study characterizing HDL properties in people with Type 2 Diabetes and dyslipidemia after treatment with fenofibrate or …
-
CLINICAL_TRIALS trial_result · 2014-06-03Clinical Trial Update: Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic Control [Phase 4]
Update on a Phase 4 trial evaluating linagliptin in combination with metformin for treatment-naive patients with Type 2 diabetes mellitus an…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: Effects of Sitagliptin on Type 2 Diabetes Mellitus Patients on Treatment With Metformin and Insulin [Phase 4]
A completed Phase 4 clinical trial evaluated the effects of sitagliptin in people with Type 2 diabetes mellitus who are treated with both me…
-
CLINICAL_TRIALS trial_result · 2014-05-30Clinical Trial Update: A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312) [Phase 3]
Phase 3 trial evaluating the safety and tolerability of a sitagliptin/simvastatin fixed-dose combination in adults with type 2 diabetes inad…
-
CLINICAL_TRIALS trial_result · 2014-05-29Clinical Trial Update: Heritage Study--Genetics, Exercise and Risk Factors [NA]
A completed clinical trial update from Washington University School of Medicine focusing on genetics, exercise, and risk factors related to …
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: Effect of Vildagliptin in Type 2 Diabetes Treated With Sulphonylurea and Metformin [Phase 4]
Phase 4 trial evaluating the efficacy and safety of adding vildagliptin to sulphonylurea and metformin in type 2 diabetes; the study has bee…
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: Safety and Efficacy of Liraglutide in Combination With an OAD in Subjects With Type 2 Diabetes Insufficiently Controlled on OAD Alone [Phase 3]
Phase 3 trial evaluating safety and efficacy of liraglutide added to oral antidiabetic drugs in adults with Type 2 diabetes inadequately con…
-
CLINICAL_TRIALS research · 2014-05-28Clinical Trial Update: A Cross-Sectional Survey to Evaluate Diabetes Management, Control, Complications, Psychosocial Aspects of Patients With Type 2 Diabetes in Indonesia
A completed cross-sectional survey examining how Indonesian patients with Type 2 diabetes manage their condition, including control, complic…
-
CLINICAL_TRIALS research · 2014-05-28Clinical Trial Update: Ubiquitous Healthcare for Elderly Patients With Type 2 Diabetes Mellitus [NA]
This clinical trial update reports that the study examining ubiquitous healthcare for elderly patients with type 2 diabetes mellitus has com…
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: Effectiveness of Metformin Compared to Insulin in Pregnant Women With Mild Preexisting or Early Gestational Diabetes [Phase 2]
Phase 2 trial comparing metformin to insulin in pregnant women with mild preexisting or early gestational diabetes; the study is completed w…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: Pharmacokinetics/Pharmacodynamics of Albiglutide [Phase 2]
Phase 2 pharmacokinetic/pharmacodynamic data for albiglutide in type 2 diabetes patients are reported. The results describe exposure-respons…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication [Phase 3]
Phase 3 trial update for dapagliflozin (BMS-512148) in adults with type 2 diabetes and inadequately controlled hypertension on an ACE inhibi…